Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 59-68

  Philip, Ramila ^a   Clary, Bryan ^b   Brunette, Elisa ^a   Kilinski, Lydia ^a   Murugesh, Deepa ^a   Sorich, Martin ^a   Yau, Josephine ^a   Lebkowski, Jane ^a   Lyerly, H Kim ^b   Philip, Mohan ^a  

^a Applied Immune Sciences   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; INTERLEUKIN 2;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; OVARY CANCER; PRIORITY JOURNAL;

BLOTTING, SOUTHERN; BREAST NEOPLASMS; DEPENDOVIRUS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOTHERAPY, ACTIVE; INTERLEUKIN-2; OVARIAN NEOPLASMS; PLASMIDS; TUMOR CELLS, CULTURED;

EID: 0030052945     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rosenberg, S. Immunotherapy of cancer using interleukin-2, current status and future prospects. Immunol. Today. 9: 58-61, 1988.
2. Kedar, E., and Klein, E. Cancer immunotherapy: are the results discouraging? Can they be improved? Adv. Cancer Res., 62: 245-322. 1993.
3. Bubenik, J., Perlmann, P., Indrova, M., Simova, J., Jandlova, T , and Neuwirt, J. Growth inhibition of an MC-induced mouse sarcoma by TCGF(IL-2) containing preparation. Cancer Immunol. Immunother., 14: 205-206, 1983.
4. Forni, G., Giovarelli, M., Santoni, A., Modesti, A., and Forni, M. Tumor inhibition by interleukin-2 at the tumor/host interface. Biochim. Biophys. Acta, 865: 307-327, 1986.
5. Porgador, A., Tzehoval, E., Katz, A., Vadai, E., Revel, M., Feldman, M., and Eisenbach, L. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res., 52: 3679-3686, 1992.
6. Porgador, A., Bannerji, R., Watanabe, Y., Feldman, M., Gilboa, E., and Eisenbach. L. Anti-metastatic vaccination of tumor-bearing mice with two types of γ-interferon gene inserted tumor cells. J. Immunol., 150: 1458-1463, 1993.
7. Porgador, A., Gansbacher, B., Bannerji, R., Tzehoval, E., Gilboa, E., Feldman, M., and Eisenbach, L. Antimetastatic vaccination of tumor bearing mice with IL-2 gene inserted tumor cells. Int. J. Cancer, 53: 471-477, 1993.
8. Connor, J., Bannerji, R., Saito, S., Heston, W., Fair, W., and Gilboa, E. Regression of bladder tumors in mice treated with interleukin-2 gene modified tumor cells. J. Exp. Med., 177: 1127-1134, 1993
9. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90: 3539-3543, 1993.
10. Vieweg, J., Rosenthal, F., Bannerji, R., Heston, W., Fair, W., Gansbacher, B., and Gilboa, E. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res., 54: 1760-1765, 1994.
11. Saito, S., Bannerji, R., Gansbacher, B., Rosenthal, F., Romanenko, P., Heston, W., Fair, W., and Gilboa, E. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res., 54: 3516-3520, 1994.
12. Allione, A., Consalvo, M. Nanni, P., Collini, P., Cavallo, F., Giovarelli, M., Forni, M., Culino, A., Colombo, M., Dellabona, P., Hock, H., Blankenstein, T., Rosenthal, F., Gansbacher, B . Bosco, M., Musso, T., Gusella, L , and Forni, G. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-1, IL10, tumor necrosis factor α, granulocyte-macrophage colony-stimulating factor, and γ-interferon gene or admixed with conventional adjuvants. Cancer Res., 54: 6022-6026, 1994.
13. Pizza, G., Severini, G., Menniti, D., DeVinci, C , and Corrado, F. Tumor regression after intralesional injection of interleukin-2 (IL-2) in bladder cancer Preliminary report. Int. J. Cancer, 34: 359, 1984
14. Jaffee, E., Dranoff, G., Cohen, L., Hauda, K., Clift, S., Marchall, F., Mulligan, R , and Pardoll, D. High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res., 53: 2221-2226, 1993.
15. Sanda, M., Ayyagari, S., Jaffee, E., Epstein, J., Clift, S., Cohen, L., Dranoff, G., Pardoll, D., Mulligan, R., and Simons, J. Demonstration of a rational strategy for human prostate cancer gene therapy. J. Urol., 151: 622-628, 1994.
16. Miller, D., Adam, M., and Miller, A. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol., 10: 4239-4242, 1990.
17. Philip, R., and Debs, R. Cationic liposome mediated transfection of immune effector cells. J. Liposome Res., 3: 71-84, 1993.
18. Philip, R., Brunette, E., Kilinski, L., Murugesh, D., McNally, M., Ucar, K., Rosenblatt, J., Okarma, T., and Lebkowski, J. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol. Cell. Biol., 14: 2411-2418, 1994.
19. Huang, M., and Gorman, C. Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res., 18: 937-947, 1990.
20. Laughlin, C. A., Tratschin, J. D., Coon, H., and Carter, B. J. Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene (Amst.), 23: 65-73, 1983.
21. Cullen, B. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell, 46: 973-982, 1986.
22. Vieweg, J., Boczkowski, D., Roberson, K., Edwards, D., Philip, M., Philip, R., Rudoll, T., Smith, C., Robertson, C., and Gilboa, E. Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer. Cancer Res., 55: 2366-2372, 1995.
23. Jung, R., Schauer, U., Heusser, C., Neumann, C., and Rieger, C. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods, 159: 197-207, 1993.
24. Lotze, M., Rubin, J., Carty, S., Edington, H., Ferson, P., Landreneau, R , Pippin B., Posner, M., Rosenfelder, R., Watson, C., Carlos, T., Kirkwood, J., Lembersky, B., Logan, T., Rosenstein, M., Rybak, M., Whiteside, T., Elder, E., Moen, R., Jacob, W., Chen, Y., Pinkus, R., and Bryant, J. Gene therapy of cancer a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response. Hum Gene Ther., 5: 41-55, 1994.
25. Lebkowski, J., McNally, M., Okarma, T., and Lerch, L. Adeno-associated virus: a vector system of efficient introduction and integration of DNA into a variety of mammalian cell types. Mol. Cell. Biol., 8: 3988-3996, 1988.
26. Podsakoff, G., Wong, K. K., Jr., and Chatterjee, S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol., 68: 5656-5666, 1994.
27. Felgner, P., Northrop, J., Ringold, G., and Danielsen, M. A highly efficient, lipid-mediated DNA transfection procedure. Proc. Natl. Acad. Sci. USA, 84: 7413-7417, 1987.
28. Rose, J., Buonocore, L., and Whitt, M. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques, 10: 520-522, 1991.